BioBlast Pharma (ORPN) Tops Q2 EPS by 5c

August 25, 2016 8:11 AM EDT
Get Alerts ORPN Hot Sheet
Trade ORPN Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

BioBlast Pharma (Nasdaq: ORPN) reported Q2 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27).

Cash and cash equivalents (including short-term bank deposits) totaled $15.7 million at June 30, 2016, compared with $19.3 million at December 31, 2015.

For earnings history and earnings-related data on BioBlast Pharma (ORPN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment